SUMMARY The effect of pharmacological constriction of the lower oesophageal sphincter (LOS) on oesophageal varices was investigated in an experimental study followed by a controlled clinical trial. In the experimental study intravariceal pressure was measured just above the LOS in 11 patients before and after constricting the LOS by intravenous pentagastrin. Intravariceal pressure fell from a mean of 23 (range 12-36) 
Pharmacological constriction of the lower oesophageal sphincter: a simple method of arresting variceal haemorrhage S W HOSKING, W DOSS, H EL-ZEINY, P ROBINSON, M S BARSOUM, AND A G JOHNSON From the Departments ofSurgery, Royal Hallamshire Hospital, Sheffield and Kasr El Aini Hospital, Cairo, Egypt SUMMARY The effect of pharmacological constriction of the lower oesophageal sphincter (LOS) on oesophageal varices was investigated in an experimental study followed by a controlled clinical trial. In the experimental study intravariceal pressure was measured just above the LOS in 11 patients before and after constricting the LOS by intravenous pentagastrin. Intravariceal pressure fell from a mean of 23 (range 12-36) mmHg to 4 (range 0-7) mmHg (p<0 001). This marked pressure drop indicated the considerable compression of varices that occurred within the LOS. A prospective controlled clinical trial examined whether LOS constriction (effected by the longer acting metoclopramide) would compress varices sufficiently to arrest active variceal bleeding originating from the lowest 2 cm oesophagus -the area encircled by the LOS. Of 11 patients who received metoclopramide, 10 stopped bleeding compared with four of the 11 who received placebo (p<0-01). Pharmacological constriction of the LOS appears to offer a new and effective approach for arresting active bleeding from oesophageal varices.
Bleeding from oesophageal varices is a serious complication of portal hypertension. The two groups were well matched for age, sex ratio, Child's grading, degree of shock, and size of varices (Table) . The aetiology of each patient's portal hypertension was based on the history, and supported by a liver biopsy in five patients.
Of the 11 patients who received metoclopramide injection, 10 patients had stopped bleeding when reendoscoped 15 minutes after the initial endoscopy. One patient who had a spurting varix failed to stop bleeding after metoclopramide. In contrast, only four of the control patients had stopped bleeding but seven continued to bleed at the second endoscopy. Using X2 analysis with Yates' correction this proved to be a significant difference (p<0.01). Of the seven control patients who continued to bleed, sclerotherapy failed in two patients to arrest bleeding and a Sengstaken tube was required in both. In the other five patients, sclerotherapy was done with considerable difficulty but eventually controlled the bleeding.
Discussion
These results indicate that pharmacological constriction of the lower oesophageal sphincter is an effective alternative approach to the problem of actively bleeding oesophageal varices. Previous studies have shown the effect of LOS constriction on variceal blood flow to be considerable. Portographic studies indicate that LOS constrictors such as domperidone, metoclopramide, and pentagastrin all reduce or even abolish blood flow in submucosal oesophageal varices'6 whilst not affecting flow in paraoesophageal varices. These findings are supported further by studies of azygous blood flow, where Mastai et al" showed in patients with varices that the same drugs reduce azygous blood flow without altering cardiovascular haemodynamics. It was concluded that the effect was the result of their constricting action on the LOS and resultant reduction of submucosal variceal flow. The results obtained from these two forms of investigation are supported further by our own variceal pressures studies.
Intravenous pentagastrin has a maximal effect on the LOS after three minutes and after a further three minutes, LOS pressure returns to normal.9 In our experimental study, the effect of pentagastrin on variceal pressures were maximal between one and a half and two minutes after completion of the injection (which had been given over two minutes) and the effect had all but disappeared after a further three minutes. Further evidence for LOS constriction being responsible for the pressure changes is gained from the Doppler studies, where patients with cephalad flow showed a marked drop in intravariceal pressure measured just above the LOS, unlike those who had caudad or bidirectional flow. Even so, regardless of the direction of flow, we would still expect LOS constriction to compress varices within the LOS zone -that is, the area which is liable to bleed. Interestingly, Aronsen believed the haemostatic effect of vasopressin on bleeding oesophageal varices to be caused partly by the same mechanism based on portography and manometry in dogs.'2 In patients given vasopressin, however, portography and manometry showed little or no effect on LOS pressure or variceal flow respectively.63
The evidence of others and our own experimental study suggested that pharmacological constriction of the LOS may be of sufficient force to compress varices so as to arrest active variceal bleeding; we therefore undertook our controlled trial. Current methods of arresting active variceal bleeding such as balloon tamponade,'4 vasopressin with or without nitroglycerin,'5 somastostatin,"' or emergency sclerotherapy,'7 have limitations. These may be caused by lack of skilled nursing and medical personnel, side effects, cost of treatment, or lack of efficacy. Thus an effective, safe economic alternative is still required. The arrest of active variceal bleeding by metoclopramide appears to offer a genuine alternative to treatments already mentioned. This approach will, however, only be appropriate when bleeding originates from within the zone of the LOS. In patients with varices, the sphincter length is between 2 and 7 cm in 95% of patients"' and the squamocolumnar junction is between 0-9 and 2.1 cm from the lowest limit of the LOS.'" Therefore, in the majority of patients, pharmacological LOS constriction would be expected to affect variceal bleeding occurring from a zone extending from 1 cm below to 2 cm proximal to the squamocolumnar junction. In our experience and that of others' most variceal bleeds occur from within this zone; nonetheless we would advocate endoscopy in every patient to confirm not only the site of bleeding but also that varices are the source of bleeding. In patients kn6wn to have varices, non-variceal bleeding occurs in over half. ' Whilst arrest of active bleeding on its own does not prolong survival'4 (and must be followed by definitive treatment to prevent rebleeding), rapid and effective haemostasis will minimise the often inevitable hepatic decompensation that occurs in such patients. Metoclopramide is rather short acting"' and longer acting drugs under evaluation such as cisapride" may be of more use, particularly to non-specialist centres allowing stabilisation of the patient and safe transfer to another hospital, if required. Mr 
